ReviewJournal of clinical medicine2016

Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical Studies.

Ding Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.